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  The present study was to assess the effect of storage conditions 
on prothrombin time (PT), activated partial thromboplastin 
time (aPTT) and fibrinogen concentration in blood samples 
of healthy dogs. Thirty-five dogs of various breeds were 
included in the study. Citrated blood samples were obtained 
and plasma was divided into four aliquots to assess selected 
clotting parameters by means of a coagulometer. The first 
aliquot was analysed within 1 h after collection, while the 
remaining 3 were stored at 8
oC for 4, 8 and 24 h, respectively. 
One-way repeated measures analysis of variance documented 
a significant decreasing effect on PT at 24 h compared to 8 h 
and on fibrinogen concentration after 8 and 24 h compared 
to sampling time and at 4 and 24 h compared to 8 h post 
sampling. In conclusion, the results of this study indicate that 
only fibrinogen appears prone to significant decrease. In fact, 
aPTT is not substantially affected by refrigeration for at least 
24 h post sampling and PT showed a statistical difference that 
does not necessary indicate biological significance as the 
results obtained were within reference intervals for the dog.
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Introduction 
Prothrombin time (PT), activated partial thromboplastin 
time (aPTT) and fibrinogen concentration are widely used 
screening tests in the clinical setting for the evaluation of the 
canine coagulation profile. Although modern coagulation 
diagnostics is becoming increasingly complex, PT, aPTT 
and fibrinogen concentration are still important and reflect 
the activity of several coagulation factors of the extrinsic 
and/or the intrinsic system [10]. Clotting tests are useful in 
the diagnosis of coagulation disorders and the monitoring 
of anticoagulant therapy [3,5,9,12,15]. Measurements of 
these parameters are performed by commercial kits and 
should be performed within 2∼3 h of blood collection [4]. 
In clinical practice, recommended time allowances between 
collection and plasma analysis are frequently exceeded. 
Therefore, the potential impact of pre- analytic factors such 
as storage temperature and time in the measurements need 
to be taken into account. Previously, the effect of anticoagulant 
and storage conditions on platelet clumping has been evaluated 
in dogs [11] and the stability of canine plasma stored at room 
temperature or at 4
oC for hemostasis testing has been 
investigated at 24, 48, 72 and 96 h post sampling [6]. 
Additionally, the effect of long-term storage at 򰠏20
oC [16] 
and that of 6-month storage on hemostatic function testing 
[2] in the dog have been reported. The possible impact of 
24-h storage on PT, aPTT and fibrinogen concentration, 
however, has rarely been assessed. 
Since it is not always possible for measurement of clotting 
parameters to be completed within 3 h of blood collection, 
a good storage procedure of blood samples is necessary in 
order to obtain reliable results. For this reason, the aim of 
this study was to evaluate the potential effect of storage at 
8
oC for 4, 8 and 24 h post-sampling on PT, aPTT and 
fibrinogen concentration in the dog.
Materials and Methods
Samples
Blood samples were obtained from 35 clinically healthy 
dogs (1∼6 years old) of various breeds, including 22 
Mongrels, 6 Labrador Retrievers, 3 Canecorso, 2 Golden 122    Giuseppe Piccione et al.
Table 1. Average values of prothrombin time (PT), activated partial thromboplastin time (aPTT) and fibrinogen concentration, 
expressed in their conventional units of measurement, obtained during different experimental conditions in 35 healthy dogs
Parameters
Experimental conditions
After collection (within 1 h) After 4 h at 8
oC After 8 h at 8
oC After 24 h at 8
oC
PT (sec) Mean ± SD 7.23 ± 0.68 7.18 ± 0.70 7.57 ± 0.57 6.93 ± 0.64
‡
Median 7.20 7.00 7.60 6.91
Min∼Max 6.00∼8.40 6.20∼8.80 6.60∼8.50 5.90∼8.00
aPTT (sec) Mean ± SD 12.45 ± 0.86 12.42 ± 0.80 12.73 ± 0.99 12.51 ± 0.55
Median 12.70 12.40 12.90 12.70
Min∼Max 10.00∼13.60 10.90∼13.80 11.00∼14.00 11.60∼13.10
Fibrinogen
 (mg/dL)
Mean ± SD 321.50 ± 31.19 336.40 ± 37.28  287.90 ± 39.76*,† 228.20 ± 22.90*,†,‡
Median 320.00 334.30 287.00 228.00
Min∼Max 260.00∼380.00 260.00∼402.80 220.00∼369.40 181.00∼270.00
*p＜0.001 compared to after collection, 
†p＜0.001 compared to after 4 h, 
‡p＜0.001 compared to after 8 h.
Retrievers and 2 Boxers. Dogs were deemed healthy if they 
did not have a history of haemostatic and haematological 
disorders and if no abnormalities were found on physical 
examination and complete blood count. No pharmacological 
treatment was administered for one month prior to the study.
Blood was collected from the cephalic vein and within 20 
sec it was transferred into two tubes containing K3- 
ethylenediaminetetraacetic acid (K3-EDTA) and 3.8% sodium 
citrate, respectively. On EDTA-anticoagulated samples, a 
complete blood count was performed in an automatic 
haematology analyzer (HecoVet; SEAC, Italy) within 30 min. 
Citrated-anticoagulated blood samples were immediately 
centrifuged (Thermo Scientific CL10 centrifuge) at 3,000 
g × 15 min, plasma was removed with a plastic pipette and 
transferred into Eppendorf microtubes. Plasma samples 
were divided into four aliquots to assess PT, aPTT and 
fibrinogen concentration by means of an automatic 
coagulometer (Clot 2; SEAC, Italy) according to the 
manufacturer’s instructions and to a standard protocol to 
exclude differences that result from dissimilar test procedures. 
The first aliquot was analysed within 1 h of blood collection, 
the second after refrigeration at 8
oC for 4 h, the third after 
refrigeration at 8
oC for 8 h and the fourth after refrigeration 
at 8
oC for 24 h.
PT test
The PT was assessed by means of a standard kit suitable for 
the SEAC Clot 2 coagulometer. The assay procedure consisted 
of placing 200 μL of tissue factor (PT reagent) in a test tube 
preheated to 37
oC, and subsequently adding 100 μL of citrated 
plasma. Upon the addition of test plasma, a stopwatch was 
started and the clotting time was measured. The time, 
expressed in seconds, from the plasma-reagent mixing to a 
visually detected clot formation was defined as the PT.
aPTT test
The aPTT was assessed by means of a standard kit suitable 
for the SEAC Clot 2 coagulometer. The assay procedure 
consisted of placing 100 μL of citrated plasma and 100 μL 
of aPTT reagent (preheated to 37
oC) in a test tube preheated 
to 37
oC, followed by incubation for 3 min at 37
oC, followed 
by the addition of 100 μL of calcium chloride (preheated to 
37
oC). Upon the addition of calcium chloride, a stopwatch 
was started and the clotting time was measured. The time, 
expressed in seconds, from this addition to a visually 
detected clot formation was defined as the aPTT.
Fibrinogen determination
Fibrinogen concentration was determined by means of a 
standard kit suitable for the SEAC Clot 2 coagulometer. The 
assay procedure consisted of placing 200 μL of 1 : 10 (100 μL 
of plasma + 900 μL of buffer) prediluted plasma in a test tube 
preheated to 37
oC, followed by incubation for 2 min at 37
oC, 
followed by addition of 100 μL of the fibrinogen reagent. Upon 
the addition of fibrinogen reagent, a stopwatch was started and 
the clotting time was measured. For each assay, the results in 
seconds were automatically converted into mg/dL by an 
automated mechanical endpoint coagulation instrument.
Statistical analyses
All results were expressed as mean ± SD. One-way repeated 
measures analysis of variance (ANOVA) was used to determine 
significant differences. p values ＜ 0.05 were considered 
statistically significant. Bonferroni’s multiple comparison 
test was applied for post hoc comparison. Data were analyzed 
using the software (Statistica 7.0; StastSoft, USA).Stability of stored canine plasma for clotting parameters    123
Results
Table 1 shows the mean values of PT, aPTT and fibrinogen 
concentration obtained in the different experimental 
conditions in 35 healthy dogs, together with standard 
deviations and statistical significances.
One-way repeated measures ANOVA showed a statistical 
significant effect of the storage conditions on PT (F(3,102) = 
6.51; p = 0.0004) and fibrinogen concentration (F(3,102) = 
75.59; p ＜ 0.0001). Bonferroni’s multiple comparison test 
showed that there was a statistically significant effect of 
the storage condition as follows: PT decreased after 24 h 
vs. after 8 h (p ＜ 0.001) and fibrinogen concentration 
decreased after 8 and 24 h vs. after collection (p ＜ 0.001), 
decreased after 8 and 24 h vs. after 4 h (p ＜ 0.001) and 
decreased after 24 h vs. after 8 h (p ＜ 0.001).
Discussion
The results of this study suggest that storage of canine 
plasma at 8
oC has a significant effect on certain hemostatic 
parameters of canine plasma, including PT and fibrinogen 
concentration, while storage at 8
oC for up to 24 h has an 
insignificant effect on aPPT.
In contrast to another study which demonstrated no 
significant differences for clotting parameters when samples 
were stored at room temperature [15], the present study 
suggested instability of clotting factors when stored at 8
oC. 
In our study, PT decreased 24 h after storage at 8
oC in 
accordance with several studies in humans [7,13] and in 
dogs [6]. This instability at low temperatures may be the 
result of clot-induced activation of proteolytic enzymes 
that are responsible for the slow degradation of factors 
VIII, IX and XI [8]. PT, in fact, reflects the activities of 
multiple factors and it has been shown that a significant 
decrease in any one factor must occur before PT becomes 
significantly prolonged [6].
In our study, fibrinogen concentration decreased 8 and 24 
h after storage at 8
oC. In contrast to one study that assessed 
the effect of freezing on fibrinogen levels [14], refrigeration 
in this study apparently had a decreasing effect on fibrinogen 
concentration similar to that of storage at room temperature 
observed previously [15]. The decrease induced by the 
storage was minimal but statistically significant. This 
variation is due to conformational changes of fibrinogen 
triggered by refrigeration resulting in an altered precipitation 
tendency. The final turbidity of a fibrin clot generated from 
previously refrigerated fibrinogen appears to be greater 
than the turbidity of a fibrin clot formed from fresh plasma 
[1]; this difference can be demonstrated by kinetic assay, 
indicating that the changes induced by refrigeration affect 
the fibrinogen concentration. 
We can conclude that samples are quite stable for a few 
hours post sampling if stored at 8
oC. In fact, the results of 
this study indicate that only fibrinogen appears prone to 
significant decrease. aPTT was not substantially affected 
by refrigeration for at least 24 h post sampling and PT 
showed a statistical difference that does not necessarily 
indicate biological significance as the results obtained 
were within reference intervals for the dog. 
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